financetom
Business
financetom
/
Business
/
Diebold Nixdorf, Bankart Collaborate to Revamp Payment Processing in Southeast Europe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Diebold Nixdorf, Bankart Collaborate to Revamp Payment Processing in Southeast Europe
May 13, 2024 8:10 AM

10:46 AM EDT, 05/13/2024 (MT Newswires) -- Diebold Nixdorf ( DBD ) said Monday that Bankart, a payment processor in Slovenia and the surrounding areas, is transitioning its payment services using the company's Vynamic Transaction Middleware.

Financial details weren't disclosed.

This cloud-native solution is expected to enhance payment capabilities for automated teller machines, point of sale terminals, e-commerce, and other systems across 20 banks in six southeastern European countries, the company said.

Shares of Diebold Nixdorf ( DBD ) were up 2.8% in recent trading.

Price: 42.14, Change: +1.14, Percent Change: +2.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LanzaJet, Haffner Energy, LanzaTech Partner to Develop Biomass-to-SAF Projects
LanzaJet, Haffner Energy, LanzaTech Partner to Develop Biomass-to-SAF Projects
Jan 28, 2025
04:44 AM EST, 01/28/2025 (MT Newswires) -- LanzaTech Global ( LNZA ) , Haffner Energy, and LanzaJet said Tuesday they are joining forces to pursue the production of Sustainable Aviation Fuel, or SAF, from biomass residues, covering the full production process. The collaboration will focus on building commercial facilities, sharing technology licenses, securing funding, and establishing agreements for SAF supply,...
AstraZeneca, Daiichi Sankyo's Enhertu Gets US FDA Approval for Treatment of Inoperable Breast Cancers
AstraZeneca, Daiichi Sankyo's Enhertu Gets US FDA Approval for Treatment of Inoperable Breast Cancers
Jan 28, 2025
04:57 AM EST, 01/28/2025 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said their drug Enhertu has been approved in the US for the treatment of adult patients with certain types of inoperable breast cancer that has progressed on one or more endocrine therapies. The drug, also known as fam-trastuzumab deruxtecan-nxki, has specifically been approved for use in...
Fundstrat's Tom Lee Sees Nvidia's 17% Plunge As An 'Opportunity,' Calls Nasdaq's Over 600 Points Plunge Drop A Market 'Overreaction'
Fundstrat's Tom Lee Sees Nvidia's 17% Plunge As An 'Opportunity,' Calls Nasdaq's Over 600 Points Plunge Drop A Market 'Overreaction'
Jan 28, 2025
Fundstrat Global Advisors‘ head of research Tom Lee believes Monday’s massive tech sector sell-off, which saw Nvidia Corp. ( NVDA ) shares plunge 17%, represents a buying opportunity rather than a fundamental shift in the artificial intelligence landscape. What Happened: “To me, it’s an overreaction,” Lee told CNBC’s “Closing Bell,” comparing the drop to Nvidia’s March 2020 decline that proved...
Update: Chevron Cabinda Gulf Operations Resume After Release of Oil
Update: Chevron Cabinda Gulf Operations Resume After Release of Oil
Jan 28, 2025
04:58 AM EST, 01/28/2025 (MT Newswires) -- (Updates with attribution to Chevron ( CVX ) throughout and additional information in the last two paragraphs.) Chevron ( CVX ) said its Cabinda Gulf Oil operations in Angola have resumed normal operations after an oil sheen and debris were found nearby along the Atlantic Ocean coastline. About five barrels of oil were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved